Carol Pollock - Publications

Affiliations: 
University of Sydney, Camperdown, New South Wales, Australia 

95 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Chen H, Oliver BG, Pant A, Olivera A, Poronnik P, Pollock CA, Saad S. Effects of air pollution on human health - Mechanistic evidence suggested by in vitro and in vivo modelling. Environmental Research. 113378. PMID 35525290 DOI: 10.1016/j.envres.2022.113378  0.512
2021 Chen H, Oliver BG, Pant A, Olivera A, Poronnik P, Pollock CA, Saad S. Particulate Matter, an Intrauterine Toxin Affecting Foetal Development and Beyond. Antioxidants (Basel, Switzerland). 10. PMID 34066412 DOI: 10.3390/antiox10050732  0.49
2021 Yi H, Huang C, Shi Y, Cao Q, Chen J, Chen XM, Pollock CA. Metformin Attenuates Renal Fibrosis in a Mouse Model of Adenine-Induced Renal Injury Through Inhibiting TGF-β1 Signaling Pathways. Frontiers in Cell and Developmental Biology. 9: 603802. PMID 33614642 DOI: 10.3389/fcell.2021.603802  0.314
2020 Hepburn K, Kim D, Darbar A, Pollock C. Unusual cause of headache following renal transplantation. Nephrology (Carlton, Vic.). e13750. PMID 32666657 DOI: 10.1111/Nep.13750  0.305
2020 Shi Y, Chen X, Huang C, Pollock C. RIPK3: A New Player in Renal Fibrosis. Frontiers in Cell and Developmental Biology. 8: 502. PMID 32613000 DOI: 10.3389/Fcell.2020.00502  0.394
2020 Shi Y, Huang C, Zhao Y, Cao Q, Yi H, Chen X, Pollock C. RIPK3 blockade attenuates tubulointerstitial fibrosis in a mouse model of diabetic nephropathy. Scientific Reports. 10: 10458. PMID 32591618 DOI: 10.1038/S41598-020-67054-X  0.381
2020 Wong MY, Saad S, Wong MG, Stangenberg S, Jarolimek W, Schilter H, Zaky A, Gill A, Pollock C. Semicarbazide-sensitive amine oxidase inhibition ameliorates albuminuria and glomerulosclerosis but does not improve tubulointerstitial fibrosis in diabetic nephropathy. Plos One. 15: e0234617. PMID 32555665 DOI: 10.1371/Journal.Pone.0234617  0.325
2020 Shi Y, Huang C, Yi H, Cao Q, Zhao Y, Chen J, Chen X, Pollock C. RIPK3 blockade attenuates kidney fibrosis in a folic acid model of renal injury. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 32542792 DOI: 10.1096/Fj.201902544Rr  0.39
2020 Jardine MJ, Zhou Z, Mahaffey KW, Oshima M, Agarwal R, Bakris G, Bajaj HS, Bull S, Cannon CP, Charytan DM, de Zeeuw D, Di Tanna GL, Greene T, Heerspink HJL, Levin A, ... ... Pollock C, et al. Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial. Journal of the American Society of Nephrology : Jasn. 31: 1128-1139. PMID 32354987 DOI: 10.1681/Asn.2019111168  0.34
2020 Sukkar L, Kang A, Hockham C, Young T, Jun M, Foote C, Pecoits-Filho R, Neuen B, Rogers K, Pollock C, Cass A, Sullivan D, Wong G, Knight J, Peiris D, et al. Incidence and Associations of Chronic Kidney Disease in Community Participants With Diabetes: A 5-Year Prospective Analysis of the EXTEND45 Study. Diabetes Care. PMID 32161053 DOI: 10.2337/Dc19-1803  0.313
2020 Panchapakesan U, Pollock C. The primary cilia in diabetic kidney disease: a tubulocentric view? The International Journal of Biochemistry & Cell Biology. 105718. PMID 32070746 DOI: 10.1016/J.Biocel.2020.105718  0.366
2020 Garcia Sanchez JJ, Carrero JJ, Kumar S, Pecoits-Filho R, James G, Lambers Heerspink H, Nolan S, Lam C, Chen T, Kanda E, Kashihara N, Kosiborod M, Lainscak M, Pollock C, Wheeler D. P0816CLINICAL CHARACTERISTICS AND EGFR AND UACR DISTRIBUTION ACCORDING TO THE 2012 KDIGO CKD CLASSIFICATION: A REPORT FROM THE US DISCOVER CKD COHORT Nephrology Dialysis Transplantation. 35. DOI: 10.1093/Ndt/Gfaa142.P0816  0.327
2020 Neuen B, Mahaffey K, Cannon CP, Jardine M, Heerspink HL, Neal B, Arnott C, Zhou Z, Charytan DM, Agarwal R, Bakris GL, De Zeeuw D, Greene T, Levin A, Wheeler DC, ... ... Pollock C, et al. EFFECTS OF CANAGLIFLOZIN ON CARDIOVASCULAR, RENAL AND SAFETY OUTCOMES BY BASELINE LOOP DIURETIC USE: DATA FROM THE CREDENCE TRIAL Journal of the American College of Cardiology. 75: 1852. DOI: 10.1016/S0735-1097(20)32479-7  0.31
2020 OSHIMA M, Wong M, Hara A, Toyama T, Jun M, Jardine M, Pollock C, Woodward M, Chalmers J, Perkovic V, Wada T. SUN-161 CIRCULATING AUTOANTIBODIES TO ERYTHROPOIETIN RECEPTOR AND KIDNEY DISEASE PROGRESSION IN TYPE 2 DIABETES MELLITUS: RESULTS FROM THE ADVANCE STUDIES Kidney International Reports. 5: S267. DOI: 10.1016/J.Ekir.2020.02.690  0.329
2020 Jardine M, Zhou Z, Heerspink H, Li Q, Agarwal R, Bakris G, Charytan D, Oh R, Pollock C, Wheeler D, Zeeuw D, Zhang H, Zinman B, Mahaffey K, Perkovic V. SAT-156 RENAL, CARDIOVASCULAR, AND SAFETY OUTCOMES OF CANAGLIFLOZIN ACCORDING TO BASELINE ALBUMINURIA: A CREDENCE SECONDARY ANALYSIS Kidney International Reports. 5: S67. DOI: 10.1016/J.Ekir.2020.02.166  0.318
2019 Cannon CP, Perkovic V, Agarwal R, Baldassarre J, Bakris G, Charytan DM, de Zeeuw D, Edwards R, Greene T, Heerspink HJL, Jardine MJ, Levin A, Li JW, Neal B, Pollock C, et al. Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Chronic Kidney Disease According to Baseline HbA1c, Including Those with HbA1c <7%: Results From the CREDENCE Trial. Circulation. PMID 31707795 DOI: 10.1161/Circulationaha.119.044359  0.378
2019 Mahaffey KW, Jardine MJ, Bompoint S, Cannon CP, Neal B, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Capuano G, de Zeeuw D, Greene T, Levin A, ... Pollock C, et al. Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups: Results from the Randomized CREDENCE Trial. Circulation. PMID 31291786 DOI: 10.1161/Circulationaha.119.042007  0.362
2019 Pollock C, Stefánsson B, Reyner D, Rossing P, Sjöström CD, Wheeler DC, Langkilde AM, Heerspink HJL. Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial. The Lancet. Diabetes & Endocrinology. PMID 30992195 DOI: 10.1016/S2213-8587(19)30086-5  0.372
2019 Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Cannon CP, Capuano G, Chu PL, de Zeeuw D, Greene T, ... ... Pollock C, et al. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. The New England Journal of Medicine. PMID 30990260 DOI: 10.1056/Nejmoa1811744  0.371
2018 van der Plas WY, Engelsman AF, Umakanthan M, Mather A, Sidhu SB, Delbridge LW, Pollock C, Waugh D, Sywak MS, Kruijff S. Treatment strategy of end-stage renal disease related hyperparathyroidism before, during, and after the era of calcimimetics. Surgery. PMID 30413324 DOI: 10.1016/J.Surg.2018.04.092  0.323
2018 Panchapakesan U, Pollock C. Drug repurposing in kidney disease. Kidney International. PMID 29628139 DOI: 10.1016/J.Kint.2017.12.026  0.353
2017 Pollock C, Zuk A, Anders HJ, Ganji MR, Johnson DW, Kasiske B, Langham RG, Pecoits-Filho R, Remuzzi G, Rossert J, Suzuki Y, Tanaka T, Walker R, Yang CW, Bonventre JV. The establishment and validation of novel therapeutic targets to retard progression of chronic kidney disease. Kidney International Supplements. 7: 130-137. PMID 30675427 DOI: 10.1016/J.Kisu.2017.07.008  0.306
2017 Obrador GT, Schultheiss UT, Kretzler M, Langham RG, Nangaku M, Pecoits-Filho R, Pollock C, Rossert J, Correa-Rotter R, Stenvinkel P, Walker R, Yang CW, Fox CS, Köttgen A. Genetic and environmental risk factors for chronic kidney disease. Kidney International Supplements. 7: 88-106. PMID 30675423 DOI: 10.1016/J.Kisu.2017.07.004  0.321
2017 Jardine MJ, Mahaffey KW, Neal B, Agarwal R, Bakris GL, Brenner BM, Bull S, Cannon CP, Charytan DM, de Zeeuw D, Edwards R, Greene T, Heerspink HJL, Levin A, Pollock C, et al. The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics. American Journal of Nephrology. 46: 462-472. PMID 29253846 DOI: 10.1159/000484633  0.413
2017 d'Emden M, Amerena J, Deed G, Pollock C, Cooper ME. SGLT2 inhibitors with cardiovascular benefits: Transforming clinical care in Type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 136: 23-31. PMID 29196150 DOI: 10.1016/J.Diabres.2017.11.023  0.332
2017 Nguyen LT, Chen H, Pollock C, Saad S. SIRT1 reduction is associated with sex-specific dysregulation of renal lipid metabolism and stress responses in offspring by maternal high-fat diet. Scientific Reports. 7: 8982. PMID 28827681 DOI: 10.1038/S41598-017-08694-4  0.316
2017 Levin A, Tonelli M, Bonventre J, Coresh J, Donner JA, Fogo AB, Fox CS, Gansevoort RT, Heerspink HJL, Jardine M, Kasiske B, Köttgen A, Kretzler M, Levey AS, Luyckx VA, ... ... Pollock C, et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet (London, England). PMID 28434650 DOI: 10.1016/S0140-6736(17)30788-2  0.307
2016 Gallo LA, Ward MS, Fotheringham AK, Zhuang A, Borg DJ, Flemming NB, Harvie BM, Kinneally TL, Yeh SM, McCarthy DA, Koepsell H, Vallon V, Pollock C, Panchapakesan U, Forbes JM. Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice. Scientific Reports. 6: 26428. PMID 27226136 DOI: 10.1038/Srep26428  0.424
2015 Gangadharan Komala M, Gross S, Zaky A, Pollock C, Panchapakesan U. Linagliptin Limits High Glucose Induced Conversion of Latent to Active TGFß through Interaction with CIM6PR and Limits Renal Tubulointerstitial Fibronectin. Plos One. 10: e0141143. PMID 26509887 DOI: 10.1371/Journal.Pone.0141143  0.438
2015 Panchapakesan U, Pollock C. The Role of Dipeptidyl Peptidase - 4 Inhibitors in Diabetic Kidney Disease. Frontiers in Immunology. 6: 443. PMID 26379674 DOI: 10.3389/Fimmu.2015.00443  0.383
2015 Gangadharan Komala M, Gross S, Zaky A, Pollock C, Panchapakesan U. Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes. Nephrology (Carlton, Vic.). PMID 26375854 DOI: 10.1111/Nep.12618  0.41
2015 Mreich E, Chen XM, Zaky A, Pollock CA, Saad S. The role of Krüppel-like factor 4 in transforming growth factor-β-induced inflammatory and fibrotic responses in human proximal tubule cells. Clinical and Experimental Pharmacology & Physiology. 42: 680-6. PMID 25882815 DOI: 10.1111/1440-1681.12405  0.306
2015 Zhang J, Wong MG, Wong M, Gross S, Chen J, Pollock C, Saad S. A cationic-independent mannose 6-phosphate receptor inhibitor (PXS64) ameliorates kidney fibrosis by inhibiting activation of transforming growth factor-β1. Plos One. 10: e0116888. PMID 25658916 DOI: 10.1371/Journal.Pone.0116888  0.377
2014 Moses RG, Colagiuri S, Pollock C. SGLT2 inhibitors: New medicines for addressing unmet needs in type 2 diabetes. The Australasian Medical Journal. 7: 405-15. PMID 25379062 DOI: 10.4066/Amj.2014.2181  0.371
2014 Mudaliar H, Pollock C, Ma J, Wu H, Chadban S, Panchapakesan U. The role of TLR2 and 4-mediated inflammatory pathways in endothelial cells exposed to high glucose. Plos One. 9: e108844. PMID 25303153 DOI: 10.1371/Journal.Pone.0108844  0.357
2014 Al-Odat I, Chen H, Chan YL, Amgad S, Wong MG, Gill A, Pollock C, Saad S. The impact of maternal cigarette smoke exposure in a rodent model on renal development in the offspring. Plos One. 9: e103443. PMID 25058584 DOI: 10.1371/Journal.Pone.0103443  0.336
2014 Huang C, Lin MZ, Cheng D, Braet F, Pollock CA, Chen XM. Thioredoxin-interacting protein mediates dysfunction of tubular autophagy in diabetic kidneys through inhibiting autophagic flux. Laboratory Investigation; a Journal of Technical Methods and Pathology. 94: 309-20. PMID 24492284 DOI: 10.1038/labinvest.2014.2  0.317
2014 Mudaliar H, Pollock C, Panchapakesan U. Role of toll-like receptors in diabetic nephropathy Clinical Science. 126: 685-694. PMID 24490813 DOI: 10.1042/Cs20130267  0.329
2014 Huang C, Day ML, Poronnik P, Pollock CA, Chen XM. Inhibition of KCa3.1 suppresses TGF-β1 induced MCP-1 expression in human proximal tubular cells through Smad3, p38 and ERK1/2 signaling pathways. The International Journal of Biochemistry & Cell Biology. 47: 1-10. PMID 24291552 DOI: 10.1016/J.Biocel.2013.11.017  0.593
2013 Jenkin KA, McAinch AJ, Briffa JF, Zhang Y, Kelly DJ, Pollock CA, Poronnik P, Hryciw DH. Cannabinoid receptor 2 expression in human proximal tubule cells is regulated by albumin independent of ERK1/2 signaling. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 32: 1309-19. PMID 24280624 DOI: 10.1159/000354529  0.594
2013 Pegg K, Zhang J, Pollock C, Saad S. Combined Effects of PPAR γ Agonists and Epidermal Growth Factor Receptor Inhibitors in Human Proximal Tubule Cells. Ppar Research. 2013: 982462. PMID 23533381 DOI: 10.1155/2013/982462  0.395
2013 Panchapakesan U, Pegg K, Gross S, Komala MG, Mudaliar H, Forbes J, Pollock C, Mather A. Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy? Plos One. 8: e54442. PMID 23390498 DOI: 10.1371/Journal.Pone.0054442  0.425
2013 Komala MG, Panchapakesan U, Pollock C, Mather A. Sodium glucose cotransporter 2 and the diabetic kidney. Current Opinion in Nephrology and Hypertension. 22: 113-9. PMID 23042029 DOI: 10.1097/Mnh.0B013E32835A17Ae  0.375
2013 Panchapakesan U, Mather A, Pollock C. Role of GLP-1 and DPP-4 in diabetic nephropathy and cardiovascular disease. Clinical Science (London, England : 1979). 124: 17-26. PMID 22963445 DOI: 10.1042/Cs20120167  0.367
2012 Macdougall IC, Roger SD, de Francisco A, Goldsmith DJ, Schellekens H, Ebbers H, Jelkmann W, London G, Casadevall N, Hörl WH, Kemeny DM, Pollock C. Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights. Kidney International. 81: 727-32. PMID 22336988 DOI: 10.1038/Ki.2011.500  0.323
2011 Mather A, Pollock C. Glucose handling by the kidney. Kidney International. Supplement. S1-6. PMID 21358696 DOI: 10.1038/Ki.2010.509  0.383
2011 Panchapakesan U, Pollock C, Saad S. Renal epidermal growth factor receptor: its role in sodium and water homeostasis in diabetic nephropathy. Clinical and Experimental Pharmacology & Physiology. 38: 84-8. PMID 21155863 DOI: 10.1111/J.1440-1681.2010.05472.X  0.37
2010 Mather A, Pollock C. Renal glucose transporters: novel targets for hyperglycemia management. Nature Reviews. Nephrology. 6: 307-11. PMID 20351704 DOI: 10.1038/Nrneph.2010.38  0.383
2009 Chen XM, Qi W, Pollock CA. CTGF and chronic kidney fibrosis. Frontiers in Bioscience (Scholar Edition). 1: 132-41. PMID 19482689  0.308
2009 Panchapakesan U, Pollock C, Saad S. Review article: importance of the kidney proximal tubular cells in thiazolidinedione-mediated sodium and water uptake. Nephrology (Carlton, Vic.). 14: 298-301. PMID 19444964 DOI: 10.1111/J.1440-1797.2009.01089.X  0.374
2008 Stevens VA, Saad S, Poronnik P, Fenton-Lee CA, Polhill TS, Pollock CA. The role of SGK-1 in angiotensin II-mediated sodium reabsorption in human proximal tubular cells Nephrology Dialysis Transplantation. 23: 1834-1843. PMID 18238849 DOI: 10.1093/Ndt/Gfm923  0.563
2008 Pollock C, Johnson DW, Hörl WH, Rossert J, Casadevall N, Schellekens H, Delage R, De Francisco A, Macdougall I, Thorpe R, Toffelmire E. Pure red cell aplasia induced by erythropoiesis-stimulating agents. Clinical Journal of the American Society of Nephrology : Cjasn. 3: 193-9. PMID 18178785 DOI: 10.2215/Cjn.02440607  0.302
2008 Wong MG, Suzuki Y, Tanifuji C, Akiba H, Okumura K, Sugaya T, Yamamoto T, Horikoshi S, Tan SY, Pollock C, Tomino Y. Peritubular ischemia contributes more to tubular damage than proteinuria in immune-mediated glomerulonephritis. Journal of the American Society of Nephrology : Jasn. 19: 290-7. PMID 18094368 DOI: 10.1681/Asn.2007020226  0.344
2008 Qi W, Chen X, Poronnik P, Pollock CA. Transforming growth factor-β/connective tissue growth factor axis in the kidney International Journal of Biochemistry and Cell Biology. 40: 9-13. PMID 17300978 DOI: 10.1016/J.Biocel.2007.01.006  0.577
2008 POLLOCK C, VOSS D, HODSON E, CROMPTON C. Nutrition and Growth in Kidney Disease Nephrology. 10: S177-S230. DOI: 10.1111/J.1440-1797.2005.00506.X  0.313
2007 Panchapakesan U, Sumual S, Pollock C. Nanomedicines in the treatment of anemia in renal disease: focus on CERA (Continuous Erythropoietin Receptor Activator). International Journal of Nanomedicine. 2: 33-8. PMID 17722510 DOI: 10.2147/Nano.2007.2.1.33  0.322
2007 Pollock CA, Poronnik P. Albumin transport and processing by the proximal tubule: Physiology and pathophysiology Current Opinion in Nephrology and Hypertension. 16: 359-364. PMID 17565279 DOI: 10.1097/Mnh.0B013E3281Eb9059  0.576
2007 JOHNSON DW, BREW BK, PORONNIK P, COOK DI, GYÖRY AZ, FIELD MJ, POLLOCK CA. Transport characteristics of human proximal tubule cells in primary culture Nephrology. 3: 183-194. DOI: 10.1111/j.1440-1797.1997.tb00213.x  0.522
2006 Hryciw DH, Ekberg J, Ferguson C, Lee A, Wang D, Parton RG, Pollock CA, Yun CC, Poronnik P. Regulation of albumin endocytosis by PSD95/Dlg/ZO-1 (PDZ) scaffolds. Interaction of Na+-H+ exchange regulatory factor-2 with ClC-5. The Journal of Biological Chemistry. 281: 16068-77. PMID 16601121 DOI: 10.1074/Jbc.M512559200  0.56
2006 Qi W, Chen X, Poronnik P, Pollock CA. The renal cortical fibroblast in renal tubulointerstitial fibrosis International Journal of Biochemistry and Cell Biology. 38: 1-5. PMID 16230044 DOI: 10.1016/J.Biocel.2005.09.005  0.591
2006 Hryciw DH, Ekberg J, Pollock CA, Poronnik P. ClC-5: a chloride channel with multiple roles in renal tubular albumin uptake. The International Journal of Biochemistry & Cell Biology. 38: 1036-42. PMID 16226913 DOI: 10.1016/J.Biocel.2005.09.009  0.574
2005 Saad S, Stevens VA, Wassef L, Poronnik P, Kelly DJ, Gilbert RE, Pollock CA. High glucose transactivates the EGF receptor and up-regulates serum glucocorticoid kinase in the proximal tubule Kidney International. 68: 985-997. PMID 16105029 DOI: 10.1111/J.1523-1755.2005.00492.X  0.585
2005 Pollock C. Pathogenesis of peritoneal sclerosis. The International Journal of Artificial Organs. 28: 90-6. PMID 15770596 DOI: 10.1177/039139880502800203  0.323
2005 Zafiriou S, Stanners SR, Saad S, Polhill TS, Poronnik P, Pollock CA. Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts Journal of the American Society of Nephrology. 16: 638-645. PMID 15689403 DOI: 10.1681/ASN.2004040278  0.575
2005 Hryciw DH, Pollock CA, Poronnik P. PKC-α-mediated remodeling of the actin cytoskeleton is involved in constitutive albumin uptake by proximal tubule cells American Journal of Physiology - Renal Physiology. 288: F1227-F1235. PMID 15657300 DOI: 10.1152/Ajprenal.00428.2003  0.544
2005 Qi W, Twigg S, Chen X, Polhill TS, Poronnik P, Gilbert RE, Pollock CA. Integrated actions of transforming growth factor-β1 and connective tissue growth factor in renal fibrosis American Journal of Physiology - Renal Physiology. 288: F800-F809. PMID 15536170 DOI: 10.1152/Ajprenal.00179.2004  0.544
2004 Hryciw DH, Ekberg J, Lee A, Lensink IL, Kumar S, Guggino WB, Cook DI, Pollock CA, Poronnik P. Nedd4-2 functionally interacts with ClC-5: involvement in constitutive albumin endocytosis in proximal tubule cells. The Journal of Biological Chemistry. 279: 54996-5007. PMID 15489223 DOI: 10.1074/Jbc.M411491200  0.572
2004 McGinn S, Poronnik P, Gallery EDM, Pollock CA. The effects of high glucose and atorvastatin on endothelial cell matrix production Diabetic Medicine. 21: 1102-1107. PMID 15384957 DOI: 10.1111/J.1464-5491.2004.01293.X  0.546
2004 McGinn S, Poronnik P, Gallery EDM, Pollock CA. A method for the isolation of glomerular and tubulointerstitial endothelial cells and a comparison of characteristics with the human umbilical vein endothelial cell model Nephrology. 9: 229-237. PMID 15363055 DOI: 10.1111/J.1440-1797.2004.00254.X  0.578
2004 Hryciw DH, Lee EM, Pollock CA, Poronnik P. Molecular changes in proximal tubule function in diabetes mellitus Clinical and Experimental Pharmacology and Physiology. 31: 372-379. PMID 15191416 DOI: 10.1111/J.1440-1681.2004.04001.X  0.582
2004 Qi W, Poronnik P, Young B, Jackson CJ, Field MJ, Pollock CA. Human cortical fibroblast responses to high glucose and hypoxia Nephron - Physiology. 96: p121-p129. PMID 15122058 DOI: 10.1159/000077383  0.577
2004 Polhill TS, Saad S, Poronnik P, Fulcher GR, Pollock CA. Short-term peaks in glucose promote renal fibrogenesis independently of total glucose exposure American Journal of Physiology - Renal Physiology. 287: F268-F273. PMID 15113747 DOI: 10.1152/Ajprenal.00084.2004  0.574
2004 Zafiriou S, Stanners SR, Polhill TS, Poronnik P, Pollock CA. Pioglitazone increases renal tubular cell albumin uptake but limits proinflammatory and fibrotic responses Kidney International. 65: 1647-1653. PMID 15086903 DOI: 10.1111/J.1523-1755.2004.00574.X  0.596
2003 Hryciw DH, Wang Y, Devuyst O, Pollock CA, Poronnik P, Guggino WB. Cofilin interacts with ClC-5 and regulates albumin uptake in proximal tubule cell lines Journal of Biological Chemistry. 278: 40169-40176. PMID 12904289 DOI: 10.1074/Jbc.M307890200  0.571
2003 Drumm K, Lee E, Stanners S, Gassner B, Gekle M, Poronnik P, Pollock CA. Albumin and glucose effects on cell growth parameters, albumin uptake and Na+/H+-exchanger isoform 3 in OK cells Cellular Physiology and Biochemistry. 13: 199-206. PMID 12876377 DOI: 10.1159/000072422  0.63
2003 Lee EM, Pollock CA, Drumm K, Barden JA, Poronnik P. Effects of pathophysiological concentrations of albumin on NHE3 activity and cell proliferation in primary cultures of human proximal tubule cells American Journal of Physiology - Renal Physiology. 285: F748-F757. PMID 12799307 DOI: 10.1152/Ajprenal.00442.2002  0.585
2003 McGinn S, Saad S, Poronnik P, Pollock CA. High glucose-mediated effects on endothelial cell proliferation occur via p38 MAP kinase American Journal of Physiology - Endocrinology and Metabolism. 285: E708-E717. PMID 12783777 DOI: 10.1152/Ajpendo.00572.2002  0.545
2003 McGinn S, Poronnik P, King M, Gallery EDM, Pollock CA. High glucose and endothelial cell growth: Novel effects independent of autocrine TGF-β1 and hyperosmolarity American Journal of Physiology - Cell Physiology. 284: C1374-C1386. PMID 12540377 DOI: 10.1152/Ajpcell.00466.2002  0.568
2002 Harris D, Pollock C, Collins J, Disney A, Hawley C, Irish A, Kerr P, Lynn K, Makris A, Roger S, Walker R, Walker R. Darbepoetin alfa: A new erythropoietic drug for the treatment of renal anaemia Nephrology. 7. DOI: 10.1111/J.1440-1797.2002.Tb00530.X  0.345
2002 Poronnik P, Fenton-Lee C, Polhill T, Pollock C. MODULATION OF HUMAN PROXIMAL TUBULE RESPONSES TO ANGIOTENSIN II (AII) BY HIGH GLUCOSE Nephrology. 7: A72-A72. DOI: 10.1046/J.1440-1797.2002.00007-1-72.X  0.572
2002 McGinn S, Poronnik P, Gallery E, Pollock C. ATORVASTATIN'S ROLE IN MATRIX PRODUCTION IN HUMAN ENDOTHELIAL CELLS Nephrology. 7: A70-A70. DOI: 10.1046/J.1440-1797.2002.00007-1-70.X  0.563
2002 McGinn S, Poronnik P, Gallery E, Pollock C. HIGH GLUCOSE EXPOSURE INDUCES ABNORMALITIES IN HUMAN ENDOTHELIAL CELL GROWTH AND DEATH Nephrology. 7: A60-A60. DOI: 10.1046/J.1440-1797.2002.00007-1-60.X  0.594
2002 McGinn S, Poronnik P, Gallery E, Pollock C. ATORVASTATIN'S ROLE ON TGFB1 PRODUCTION BY HUMAN ENDOTHELIAL CELLS Nephrology. 7: A24-A24. DOI: 10.1046/J.1440-1797.2002.00007-1-24.X  0.562
2002 McGinn S, Poronnik P, Gallery E, Pollock C. ISOLATION OF HUMAN GLOMERULAR AND TUBULOINTERSTITIAL ENDOTHELIAL CELLS BY IMMUNOMAGNETIC SEPARATION Nephrology. 7: A23-A23. DOI: 10.1046/J.1440-1797.2002.00007-1-23.X  0.568
2002 Qi W, Poronnik P, Jackson C, Field M, Pollock C. HIGH GLUCOSE UPREGULATES PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) IN HUMAN PROXIMAL TUBULAR CELLS (PTCS) AND CORTICAL FIBROBLASTS (CFS) Nephrology. 7: A20-A20. DOI: 10.1046/J.1440-1797.2002.00007-1-20.X  0.601
2002 Drumm K, Pollock C, Poronnik P. GLUCOSE AND ALBUMIN INDUCED ENHANCEMENT OF NF-kB-SPECIFIC PROTEIN EXPRESSION IN HUMAN RENAL PROXIMAL TUBULAR CELLS Nephrology. 7: A124-A124. DOI: 10.1046/J.1440-1797.2002.00007-1-124.X  0.636
2001 Chalmers J, Cooper M, Ferrannini E, Glasziou P, Grobbee D, Hamet P, Harrap S, Liu L, MacMahon S, Mancia G, Marre M, Matthews D, Mogensen C, Neal B, Yu Pan C, ... ... Pollock C, et al. Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation Diabetologia. 44: 1118-1120. PMID 11596665 DOI: 10.1007/S001250100612  0.329
1999 Jones SC, Saunders HJ, Pollock CA. High glucose increases growth and collagen synthesis in cultured human tubulointerstitial cells. Diabetic Medicine : a Journal of the British Diabetic Association. 16: 932-8. PMID 10588523 DOI: 10.1046/j.1464-5491.1999.00174.x  0.303
1999 Johnson DW, Saunders HJ, Johnson FJ, Huq SO, Field MJ, Pollock CA. Fibrogenic effects of cyclosporin A on the tubulointerstitium: role of cytokines and growth factors. Experimental Nephrology. 7: 470-8. PMID 10559645 DOI: 10.1159/000020626  0.307
1998 Johnson DW, Saunders HJ, Brew BK, Poronnik P, Cook DI, Field MJ, Pollock CA. TGF-β1 dissociates human proximal tubule cell growth and Na+-H+ exchange activity Kidney International. 53: 1601-1607. PMID 9607190 DOI: 10.1046/J.1523-1755.1998.00916.X  0.543
1998 Johnson DW, Saunders HJ, Poronnik P, Cook DI, Field MJ, Pollock CA. Physiological changes in extracellular sodium directly control human proximal tubule growth and transport Pflugers Archiv European Journal of Physiology. 435: 211-218. PMID 9382933 DOI: 10.1007/S004240050503  0.553
1997 Johnson DW, Saunders HJ, Brew BK, Ganesan A, Baxter RC, Poronnik P, Cook DI, Györy AZ, Field MJ, Pollock CA. Human renal fibroblasts modulate proximal tubule cell growth and transport via the IGF-I axis Kidney International. 52: 1486-1496. PMID 9407494 DOI: 10.1038/Ki.1997.479  0.557
1997 Johnson DW, Brew BK, Poronnik P, Cook DI, Field MJ, Györy AZ, Pollock CA. Insulin-like growth factor I stimulates apical sodium/hydrogen exchange in human proximal tubule cells. The American Journal of Physiology. 272: F484-90. PMID 9140049 DOI: 10.1152/Ajprenal.1997.272.4.F484  0.555
1995 Pollock C, Gyory AZ, Hawkins T, Ross M, Ibels L. Comparison of simultaneous renal clearances of true endogenous creatinine and subcutaneously administered iothalamate in man. American Journal of Nephrology. 15: 277-82. PMID 7573183 DOI: 10.1159/000168849  0.342
1990 Pollock C, Liu PL, Györy AZ, Grigg R, Gallery ED, Caterson R, Ibels L, Mahony J, Waugh D. Dysmorphism of urinary red blood cells--value in diagnosis. Kidney International. 36: 1045-9. PMID 2689749 DOI: 10.1038/Ki.1989.299  0.366
Show low-probability matches.